Privacy AI
Regulatory

Health data compliance, handled.

Tell us what you need. We'll tell you what it takes and how long, before you commit.

Contact us

Summary

Contact us

The AI Act: Progressing Faster Than Expected

The European Parliament is scheduled to vote on the legislation March 13, and one of the lawmakers leading the legislation said he expects it to pass easily. Under the current timeline the law would largely take effect in 2026, although some provisions would kick in this year.

The EU Parliament has rescheduled its vote to March 13, a full month sooner than originally planned. According to statements from Members of Parliament, the parliamentary vote is expected to closely mirror the committee's decision. The Act is anticipated to be approved by a significant majority of the members.

Next Steps: Following the Parliament's vote, the Council, consisting of governments from EU member states, will officially approve the Act. According to the present schedule, the law is set to come into full effect by 2026, though certain elements may be implemented as early as this year.

Overview of the Act:

  • The Act aims to categorize AI applications according to their risk level, imposing bans on specific applications such as "emotion recognition" in workplaces, which could lead to the highest penalties: either 7% of worldwide revenue or 35 million euros (approximately $38 million), whichever is greater.
  • The legislation will affect companies operating within the 27-country bloc and developers of AI systems used in the EU, regardless of their location, including those in the USA.
  • Any company that introduces a product to the EU market will need to comply with the AI Act, meaning its products must adhere to the regulations set forth by the Act.

Click here to read more

Contact us

FAQs

Our frequently questions

No items found.

Seamus Larroque

CDPO / CPIM / ISO 27005 Certified

Find out how iliomad can help your company.

[Map placeholder]
Only visible in production
38.709099
-39.182035
1.6
6d17042a3425c5b3
Your message has been received!
We'll get back to you as soon as possible.
Something went wrong, please try again.
Home

Discover our latest articles

View All Blog Posts
Illustration of the CNIL MR-001 framework applied to a clinical trial data compliance workflow in France, showing patient data flow and security controls
September 7, 2026
GDPR
Regulation
Guideline
Regulations & Guidelines

MR-001 CNIL: what clinical trial sponsors must know about French health data compliance

Understand MR-001 CNIL obligations for clinical trial sponsors in France, from Article 32 security requirements to breach notification and cross-border data transfers.

A clinical trial coordinator reviewing an informed consent form alongside a data governance checklist, representing ICF boilerplate review and open-access database disclosure compliance
September 4, 2026
Guideline
EU Privacy Law
Regulations & Guidelines
Clinical Trials
United-Kingdom

ICF Boilerplate and Open-Access Database Disclosures: What Clinical Trial Sponsors Must Know

Learn how US site ICF boilerplate on commercial products and open-access genetic databases affects sponsor data governance, Common Rule compliance and GDPR obligations.

Abstract digital network graphic representing data protection, clinical trial compliance and cybersecurity themes for the iliomad weekly digest
September 3, 2026
Regulations & Guidelines
GDPR
Data Breach & Cybersecurity
LLMS

iliomad Weekly Digest: DPO Conflicts, Bulk Data Rules, Healthcare Cyber Incidents and AI Transparency

This week: CNIL on DPO conflicts of interest, DOJ bulk data rule for life sciences, wave of healthcare ransomware attacks, Uber's €825m GDPR fine and AI disclosure demands.